Chang P C, Grossman E, Kopin I J, Goldstein D S, Folio C J, Holmes C
Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
J Hypertens. 1995 Nov;13(11):1275-84. doi: 10.1097/00004872-199511000-00009.
The existence of presynaptic angiotensin II receptors, modulating the release of the sympathetic neurotransmitter norepinephrine, was examined in the perfused human forearm model.
In three groups out of a total of 20 healthy volunteers, intra-arterial infusions of tracer amounts of tritiated norepinephrine were given to measure forearm spillover and total plasma appearance rate of norepinephrine during intra-arterial infusions of angiotensin II (0.02, 0.2 and 2 ng/kg per min), methoxamine (0.08, 0.4 and 2 micrograms/kg per min) to produce vasoconstriction by stimulating alpha 1-adrenoceptors and saralasin (0.5 ng/kg per min) to block angiotensin II receptors. Postganglionic sympathoneural activity was stimulated by intravenous infusion of sodium nitroprusside (about 1.3 ng/kg per min) or attenuated by intravenous infusion of trimethaphan (about 1 mg/min).
Angiotensin II failed to increase the spillover and total plasma appearance rate of norepinephrine, when given without additional treatment or during sodium nitroprusside or trimethaphan administration. In contrast, the spillover of norepinephrine even decreased during angiotensin II administration, both before and during intravenous sodium nitroprusside administration, probably because of angiotensin II-induced forearm vasoconstriction. Similar vasoconstrictor doses of angiotensin II and methoxamine produced similar changes in spillover and total plasma appearance rate of norepinephrine. The highest dose of angiotensin II increased diastolic blood pressure by 9% and decreased the pulse rate by 6%. Saralasin affected the spillover and total plasma appearance rate of norepinephrine neither before nor during intravenous sodium nitroprusside infusion.
The present results fail to support the view that angiotensin II receptors exert stimulatory modulatory effects on norepinephrine release from sympathetic nerves in the human forearm, at rest or during changes in sympathoneural outflow.
在灌注的人体前臂模型中研究突触前血管紧张素II受体的存在,该受体可调节交感神经递质去甲肾上腺素的释放。
在总共20名健康志愿者中的三组中,动脉内输注微量的氚标记去甲肾上腺素,以测量在动脉内输注血管紧张素II(0.02、0.2和2 ng/kg每分钟)、甲氧明(0.08、0.4和2微克/千克每分钟)以通过刺激α1 - 肾上腺素能受体产生血管收缩以及沙拉新(0.5 ng/kg每分钟)以阻断血管紧张素II受体期间前臂去甲肾上腺素的溢出和总血浆出现率。通过静脉输注硝普钠(约1.3 ng/kg每分钟)刺激节后交感神经活动,或通过静脉输注三甲噻芬(约1毫克/分钟)减弱节后交感神经活动。
在未进行额外处理时或在硝普钠或三甲噻芬给药期间给予血管紧张素II时,其未能增加去甲肾上腺素的溢出和总血浆出现率。相反,在静脉输注硝普钠之前和期间,血管紧张素II给药期间去甲肾上腺素的溢出甚至降低,这可能是由于血管紧张素II诱导的前臂血管收缩。血管紧张素II和甲氧明的相似血管收缩剂量在去甲肾上腺素的溢出和总血浆出现率方面产生了相似的变化。血管紧张素II的最高剂量使舒张压升高9%,脉率降低6%。在静脉输注硝普钠之前或期间,沙拉新均未影响去甲肾上腺素的溢出和总血浆出现率。
目前的结果不支持血管紧张素II受体在静息或交感神经流出变化期间对人体前臂交感神经去甲肾上腺素释放发挥刺激调节作用的观点。